Archive -Year: 2022

BOSTON, MA – April 12, 2022 – Q-VANT Biosciences, the first company to achieve a 100% sustainable way to meet the growing global vaccine market...

Enhances Q-VANT’s 100% sustainable supply for next-generation saponin adjuvants Boston, MA – March 8, 2022 – Q-VANT Biosciences, the first...

Company’s Innovative Technology Increases Yield of High-Quality Saponin-Based Adjuvants, Enabling the Sustainable Supply of Billions of Doses...

Bruce Forrest recently joined the Q-VANT team as Chief Scientific Officer, bringing more than two decades of experience in vaccine and adjuvant...

The Quillaja saponaria tree is a slow-growing evergreen native to Chile whose bark has long been used for medicinal and commercial purposes....

Q-VANT Biosciences launched recently as the first company to use a computational-driven approach to solve the supply chain problem of QS-21 and...